STOCK TITAN

Firefly Neuroscience, Inc. S-3 Filings

AIFF NASDAQ

Every S-3 that Firefly Neuroscience, Inc. (AIFF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A S-3 covers the shelf registration that lets an established company sell over time, so if you follow AIFF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIFF filings page.

Rhea-AI Summary

Firefly Neuroscience, Inc. registers up to 20,499,999 shares of common stock for resale. This preliminary prospectus covers resale by the identified Selling Stockholders of Registrable Securities issued in the March 2026 private placement, including shares issued and issuable upon exercise of related warrants.

The filing states the company will not receive proceeds from sales by the Selling Stockholders, although it may receive cash if the March 2026 Warrants are exercised for cash; full cash exercise at the stated exercise prices would generate approximately $29,929,998. Shares outstanding were 15,605,821 as of June 16, 2026, and outstanding after giving effect to the issuance described is shown as 36,105,820 in the prospectus.

Rhea-AI Summary

Firefly Neuroscience, Inc. registers up to 22,500,000 shares of common stock for resale by identified selling stockholders under a shelf prospectus. The registration covers shares issuable upon exercise of multiple warrant series from March and May 2026 private placements. Firefly will not receive proceeds from Selling Stockholder resales; the company may receive proceeds only if Warrants are exercised for cash. Shares outstanding were 15,571,780 as of May 15, 2026; outstanding after giving effect to the registered issuance is stated as 38,071,780.

Rhea-AI Summary

Firefly Neuroscience, Inc. is registering up to $250,000,000 of securities under a mixed shelf offering. The company may periodically sell common stock, preferred stock, debt securities, warrants, subscription rights, and units, with specific terms and prices to be set in future prospectus supplements. Firefly’s common stock trades on the Nasdaq Capital Market under the symbol “AIFF,” and the last reported sale price on December 2, 2025 was $1.61 per share. As of that date, there were 13,492,928 shares of common stock outstanding. The company currently expects to use any net proceeds for treasury strategy, working capital and general corporate purposes while continuing to commercialize its AI-driven brain health assessment products.